Since studies have shown that α7 is the main nAChR subunit that mediates the proliferative effects of nicotine in lung cancer cells [33, 95–99], α7-nAChR might be a valuable molecular target specifically for lung cancer therapy [100–102]. This evidence concerns the gene CHRNA4 and lung carcinoma.